Preliminary Investigation of Herbal Ethosomes for Ocular Applications: Focus on Phytochemical Analysis

Ocular drug delivery poses significant challenges due to multitude of physiological and anatomical barriers of the eye, such as the blood-aqueous barrier, corneal epithelium, and fast tear turnover, which makes ocular medication administration extremely difficult. Conventional formulations, such as eye drops, are ineffective for treating infections because of these obstacles, which significantly reduce drug penetration and retention duration. Particularly for ophthalmic applications, ethosomal carriers—which are made of phospholipids, ethanol, and water—offer a promising remedy by increasing medication permeability and bioavailability. This study offers an early examination through the development of herbal Ethosomes for ocular use, with a centered emphasis on the extraction and phytochemical assessments of selected medicinal herbs. The herbs chosen—Azadirachta indica (neem) and Curcuma longa (turmeric)—are widely recognized in traditional medicine for their potent antimicrobial, anti-inflammatory, and antioxidant properties. Standardized maceration techniques were used to hydroalcoholically extract these herbs, and the extracts were screened for the presence of key bioactive constituents such as flavonoids, alkaloids, phenolics, tannins, saponins, and terpenoids using qualitative phytochemical screening. These phytochemicals are ideal candidates for addressing ocular conditions such blepharitis, keratitis, and conjunctivitis because of their well-established antibacterial and wound-healing characteristics. By establishing the medicinal potential of the herbal extracts, this study offers a crucial basis even though the ethosomal formulation and further physicochemical assessments—such as vesicle size determination, zeta potential analysis, morphology studies, and antimicrobial activity testing—have not yet been completed. Following the incorporation of these extracts into ethosomal vesicles, a thorough assessment of formulation parameters and biological activity against gram-positive and gram-negative ocular pathogens, such as Streptococcus pneumoniae, Staphylococcus aureus, and S. epidermidis, will be conducted. This preliminary study demonstrates how combining herbal medicine with cutting-edge medication delivery technologies can result in safe, efficient, and patient-friendly treatments for eye conditions.